Albert David Limited (NSE:ALBERTDAVD)

Market Cap	4.56B
Revenue (ttm)	3.27B
Net Income (ttm)	62.94M
Shares Out	n/a
EPS (ttm)	11.03
PE Ratio	72.50
Forward PE	n/a
Dividend	5.00 (0.63%)
Ex-Dividend Date	Jul 25, 2025

Volume	1,747
Average Volume	2,726
Open	798.95
Previous Close	788.70
Day's Range	794.55 - 805.00
52-Week Range	762.60 - 1,540.00
Beta	0.04
RSI	44.58
Earnings Date	Nov 11, 2025

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1938
• Employees: 1,805
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALBERTDAVD

Financial Performance

In 2024, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.